NEW YORK (GenomeWeb) – UK-based consultancy Charles Beagrie has published an independent analysis of the value and impact of the EMBL European Bioinformatics Institute that values the center's benefits to users and funders at £1 billion ($1.4 billion) per annum at a minimum, more than 20 times the direct operational costs of the institute.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.